Valuation: Mega Lifesciences

Market Cap 32.91B 988M 868M 799M 744M 1.4B 93.96B 1.43B 9.61B 3.72B 46.12B 3.71B 3.63B 161B P/E 2026 *
14.2x
P/E 2027 * 13.4x
Enterprise Value 28.06B 843M 740M 681M 635M 1.2B 80.11B 1.22B 8.19B 3.17B 39.32B 3.16B 3.1B 137B EV / Sales 2026 *
1.89x
EV / Sales 2027 * 1.8x
Free-Float
38.61%
Yield 2026 *
4.7%
Yield 2027 * 4.97%
1 day+2.72%
1 week+9.42%
Current month+2.72%
1 month+4.86%
3 months+10.22%
6 months+12.69%
Current year+12.69%
1 week 34.75
Extreme 34.75
37.75
1 month 33.75
Extreme 33.75
37.75
Current year 31.5
Extreme 31.5
40
1 year 25.75
Extreme 25.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 15.9
Extreme 15.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 61 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Date Insider Type Main position Quantity % Market Cap.
29/04/25Buy

Chief Executive Officer

100,000 0.0115%
28/04/25Buy

Chief Executive Officer

50,000 0.0057%
28/04/25Buy

Chief Executive Officer

50,000 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+2.72%+9.42%+41.12%+0.67% 988M
-0.64%+6.67%+53.59%+154.11% 1,063B
+0.00%+5.39%+62.89%+53.44% 611B
-0.23%+6.88%+32.14%+86.34% 444B
+1.43%-0.96%+26.12%+20.22% 324B
+1.57%+0.01%+35.36%+35.57% 285B
+0.37%-0.30%+27.62%+41.88% 283B
-0.96%+1.77%-27.24%-40.65% 219B
-0.22%+2.82%+24.37%+62.75% 195B
-0.29%+0.65%+12.75%+63.45% 156B
Average +0.47%+3.25%+28.87%+47.78% 358.17B
Weighted average by Cap. +0.25%+4.16%+38.22%+77.22%

Financials

2026 *2027 *
Net sales 14.88B 447M 392M 361M 336M 634M 42.47B 647M 4.34B 1.68B 20.85B 1.68B 1.64B 72.55B 15.61B 469M 412M 379M 353M 666M 44.57B 679M 4.56B 1.77B 21.88B 1.76B 1.72B 76.14B
Net income 2.32B 69.67M 61.17M 56.3M 52.46M 98.94M 6.62B 101M 677M 262M 3.25B 262M 256M 11.31B 2.46B 73.87M 64.86M 59.7M 55.63M 105M 7.02B 107M 718M 278M 3.45B 277M 271M 12B
Net Debt -4.85B -146M -128M -118M -110M -207M -13.85B -211M -1.42B -549M -6.8B -547M -535M -23.67B -4.76B -143M -125M -115M -108M -203M -13.58B -207M -1.39B -538M -6.67B -536M -525M -23.2B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
01/07/26 THB 37.75 +2.72% 1,066,764
30/06/26 THB 36.75 +3.52% 2,488,697
29/06/26 THB 35.50 +1.43% 1,738,337
26/06/26 THB 35.00 -0.71% 1,092,935
25/06/26 THB 35.25 +2.17% 1,113,715
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
37.75THB
Average target price
41.14THB
Spread / Average Target
+8.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock